Octant is a series b startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
A therapeutics company building a platform that combines synthetic biology, high-throughput chemistry, genomics, and computation to design and test thousands of drugs in parallel to discover new treatments for complex diseases.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky